Is Mithra Pharmaceuticals SA halal to invest in?

As of July 2026, Mithra Pharmaceuticals SA 1TM.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Mithra Pharmaceuticals SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mithra Pharmaceuticals SA using these criteria to determine its compliance status.

Can Muslims buy shares of Mithra Pharmaceuticals SA?

Muslim investors may consider investing in Mithra Pharmaceuticals SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Mithra Pharmaceuticals SA classified as NOT COVERED?

Musaffa determines the Shariah status of Mithra Pharmaceuticals SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Mithra Pharmaceuticals SA updated?

The Shariah compliance status of Mithra Pharmaceuticals SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Mithra Pharmaceuticals SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Mithra Pharmaceuticals SA?

You can check the latest Shariah compliance status of Mithra Pharmaceuticals SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Mithra Pharmaceuticals SA 1TM.SG

Last Updated: Apr 30, 12:00 AM·XSTU

Mithra Pharmaceuticals SA. Stock Analysis 1TM.SG

Germany Health Care Nano Cap

Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. The company is headquartered in Flemalle, Liege. The company went IPO on 2015-06-30. The firm is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The firm provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The firm also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. The company offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The firm operates in more than 100 countries around the world and is headquartered in Liege, Belgium.

Key Statistics of Mithra Pharmaceuticals SA (1TM.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.18€0.18

Today's Open

€0.18

Volume

P/E Ratio (TTM)

Financial Metrics & Statements of Mithra Pharmaceuticals SA (1TM.SG)

Super Investors Invested in Mithra Pharmaceuticals SA (1TM.SG)

FAQ's for Mithra Pharmaceuticals SA (1TM.SG)

As of July 2026, Mithra Pharmaceuticals SA 1TM.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mithra Pharmaceuticals SA using these criteria to determine its compliance status.
Muslim investors may consider investing in Mithra Pharmaceuticals SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Mithra Pharmaceuticals SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Mithra Pharmaceuticals SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Mithra Pharmaceuticals SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.